- $2.12bn
- $2.27bn
- $1.75bn
- 84
- 66
- 65
- 84
Annual income statement for Teradata, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,836 | 1,917 | 1,795 | 1,833 | 1,750 |
| Cost of Revenue | |||||
| Gross Profit | 1,019 | 1,186 | 1,081 | 1,115 | 1,058 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 1,820 | 1,686 | 1,677 | 1,647 | 1,541 |
| Operating Profit | 16 | 231 | 118 | 186 | 209 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -24 | 192 | 67 | 117 | 164 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 129 | 147 | 33 | 62 | 114 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 129 | 147 | 33 | 62 | 114 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 129 | 147 | 33 | 62 | 114 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.24 | 1.38 | 0.349 | 0.611 | 1.2 |